H&V and Pricing Reimbursement Director (mfd)

ROLE SUMMARY

The Innovating for Growth organization is an agile efficient and innovative cluster-led model designed to unlock growth and accelerate impact for patients. It is centered on uniting colleagues under a single cluster identity leveraging AI and digital tools and fostering a culture of continuous improvement. The new structure enables dynamic resource allocation rapid learning and a start-up spirit that empowers teams to act entrepreneurially. Ultimately I4G aims to reach more patients faster with greater impact and collaboration across countries where empowered teams unlock greater value than ever before.

The H&V Pricing and reimbursement Director is responsible for providing optimal support to Country Lead to ensure that the value of all in-line and pipeline assets is adequately demonstrated and understood and revenue potential is fully realized. The role advises on Health & Value (H&V) strategies facilitates information flow between country teams and global H&V experts and develops and optimizes market access strategies. This role will collaborate with HTA lead for pipeline asset support. This position leads complex projects and mid-term plans that impact business results leveraging relationships across categories external stakeholders and making strategic decisions to solve complex problems.

ROLE RESPONSIBILITIES

Advise on H&V priorities:

• Proactively monitor external environments such as healthcare system trends payer needs and competitor strategies to identify opportunities for protecting and enhancing pricing and access conditions and channel related insights to country and global teams.
• Lead market access initiatives to develop optimized pricing and market access strategies.
• Provide consolidated inputs for lifecycle management of in-line assets.
• Advise country lead on H&V opportunities and challenges across products recommend and initiate projects and mitigation strategies to maximize business potential and interact with external Stakeholders to optimize patient access and generate impactful new projects to shape the market environment.

Provide strategic guidance and lead market access strategies and product value communication:

• Lead development of market access strategies for pipeline assets including new reimbursement applications in collaboration with HTA lead
• Lead price optimization initiatives to reflect the full potential of in-line assets.
• Lead negotiations with national payers interact with market access stakeholders including key influencers KOLs and relevant associations to establish and maintain strong relationships.
• Coordinate the development of annual H&V plans in partnership with global H&V groups.
• Articulate the clinical and economic value of products through compelling payer value propositions tailored to diverse healthcare systems and reimbursement environments.
• Monitor key decisions and activities to ensure execution is aligned to agreed strategy and realize the highest value; adjust/inform strategies accordingly.
• Partner with Medical Affairs Regulatory Clinical Development and Commercial teams to align market access initiatives with product development and launch plans.

Coordinate H&V-related functions to advise leadership and manage H&V policy reforms:

• Manage internal interactions with regulatory medical and commercial units to create a favorable market access environment and partnership opportunities adapting strategy to win in this environment.
• Ensure that above-country resources are appropriately mobilized to address H&V-related market events coordinate international impact assessment and develop recommended strategies.
• Work with other H&V team members to quantify P&L impact of policy changes.
• Support best practice sharing.

Enhance H&V capabilities and expertise:

• Identify capability needs and recommend options to raise capabilities and expertise (training secondments etc.) of market access colleagues.
• Increase market access awareness and capabilities of the overall organization.
• Support the market access team to track KPIs.
• Identify professional development opportunities for the market access team contributing to annual IDPs as needed.

QUALIFICATIONS

Basic Requirements:

• Bachelors degree in Health Policy Economics Public Health or related field; Masters or MBA preferred.
• 10 years of experience in market access pricing reimbursement or health economics at country regional or global level.
• Proven track record in securing reimbursement and driving market access strategies globally.
• Strong understanding of international healthcare systems payer dynamics and HTA processes.
• Familiarity with strategic and operating planning processes.
• Excellent communication influence management and stakeholder engagement skills.
• Experience managing cross-functional teams and complex projects in a matrixed environment.
• Experience working with people in a cross-cultural environment.
• Robust writing and presentation skills in German and English and local language.
• Ability to work under pressure take accountability for business challenges think strategically and tackle complex problems.
• Intellectual curiosity and ability to spot trends/patterns.
• Strong customer orientation; ability to see issues from the point of view of others.
• An execution mindset focused on getting things done quickly and simply.

Preferred Requirements:

• Masters degree with relevant pharmaceutical experience.
• Experience in developing and implementing market access strategies.
• Experience in health technology assessment and evidence-based medicine review.
• Proven track record of successful project management

STAKEHOLDER MANAGEMENT

Internal connections:

• Optimizing internal connections and resources to bring the best value of others (Country Lead HTA Lead Cluster Commercial Category Lead GAV PPA and External Comms) to create a collaborative expanded network.

External connections:

• Lead the conversation with key stakeholders to strengthen Pfizer Position reputation and purpose at a Country Level. Influencing and building trust /productive external partnerships with payers and/or KOLs governments regulatory agencies

Work Location Assignment:Hybrid